ADSCs are mesenchymal stem cells obtained from adipose tissue with the capacity of homing to brain cancer via stromal cell-derived factor-1α/C-X-C chemokine receptor type 4 (SDF-1α/CXCR4) signaling axis, thus could serve as therapeutic vehicles for targeted brain tumor delivery [31]. This evidence concerns the gene CXCR4 and brain neoplasm.